Introduction
PU.1 is a member of the Ets family transcription factors that recognizes a purine-rich sequence along with other members of this family including Ets-1 and Fli-1 (Klemsz et al., 1990; Wasylyk et al., 1993) . PU.1 is expressed at a moderate level in hematopoietic stem cells and the expression is up-regulated during dierentiation into mature B cells and macrophages (Chen et al., 1995) , but is down-regulated during erythroid dierentiation (Moreau-Gachelin et al., 1994) . This protein is believed to be important for hematopoietic development of these cell lineages, because the disruption of the PU.1 gene in mouse induces an early lethality of animals that lack mature B cells and macrophages (Scott et al., 1994; McKercher et al., 1996) and overexpression of PU.1 in normal bone marrow cells results in a block of erythroid dierentiation (Schuetze et al., 1993) , leading to erythroleukemia (Moreau-Gachelin et al., 1996) .
A role of PU.1 in hematopoietic cell dierentiation is also suggested by the presence of the PU.1-binding sites in enhancer elements and promoter regions of several genes that are expressed during dierentiation along cell lineages. In pre-B and B cells, PU.1 is critical for expression of the immunoglobulin genes, which requires a direct interaction with the B cell-speci®c factor NF-EM5/Pip (Pongubala et al., 1993; Eisenbeis et al., 1995) . PU.1 has also been shown to interact with the retinoblastoma (Rb) protein (Hagemeier et al., 1993) , the basal transcription factor TFIID (Hagemeier et al., 1993) and the transactivator NF-IL6b (C/EBPd) (Nagulapalli et al., 1995) . Furthermore, function of PU.1 is antagonized by nuclear receptors and vice versa (Gauthier et al., 1993) and is cooperatively augmented with AML1, Myb and C/EBP transcription factors in several myeloid-speci®c gene promoters , suggesting that PU.1 regulates many lymphoidand myeloid-speci®c gene promoters and enhancers whose activity is modulated by association with other proteins. Thus, it would be interesting to isolate novel proteins that physically interact with PU.1.
In this study, we used yeast two-hybrid system to identify such novel cellular proteins from a MEL cell cDNA library. We isolated several b-galactosidase positive clones. One of these clones was con®rmed to encode a CREB binding protein (CBP) which serve as a coactivator for a variety of transcription factors involved in growth and dierentiation (Chrivia et al., 1993; Kwok et al., 1994) . GST binding assay revealed that a portion of the transcriptional activation domain of PU.1 through 74 ± 122 directly interacts with the region spanning residues 1283 ± 1915 of CBP. In addition, CBP enhanced PU.1-mediated transcription of multimerized PU-box luc reporter constructs, suggesting that CBP acts as a coactivator for the transcription factor PU.1. Since the amounts of CBP is limited in cells (Tanaka et al., 1997) , CBP may mediate positive and negative cross talk between PU.1 and other transcription factors in the process of hematopoietic cell dierentiation.
Results
Isolation of cDNA clones encoding proteins that physically interact with PU.1
In order to identify novel proteins which can interact with PU.1, we employed the yeast two-hybrid system. We constructed two sets of fusion proteins. One is a hybrid between sequences for the DNA binding domain of the yeast transcription factor GAL4 (1 ± 147 aa) and a portion of PU.1. The second expression plasmid contains sequences for the GAL4 activation domain (768 ± 881 aa) fused to a cDNA library generated from MEL cells. HF7c yeast cells were then cotransformed with the two types of hybrid plasmids. We screened 3.9610 6 primary transformants and found that 100 clones grew on SD/-Trp-Leu-His plates. Among these clones, six were ®nally identi®ed to be positive for b-galactosidase (Figure 1a ). Sequence analyses revealed that one of these clones contained a partial cDNA insert which is identical to the mouse CREB binding protein (CBP).
To con®rm the interaction between PU.1 and CBP, two kinds of prey plasmids of CBP (313 ± 1098 aa) and CBP (1283 ± 1915 aa) fused with the GAL4 activation domain were constructed and introduced into SFY526 yeast cells together with the bait plasmid of DNA encoding fusions between the GAL4 DNA-binding domain and PU.1. Co-transformation of PU.1 with the C-terminus of CBP (1283 ± 1915 aa) showed strongly bgalactosidase positive (Figure 1b ), while that with the N-terminus of CBP (313 ± 1098 aa) did not. These results suggest that the PU.1 interacts with CBP.
PU.1 directly interacts with CBP
To prove the physical association between PU.1 and CBP, we next performed GST binding assay. A glutathione S-transferase fusion protein containing the murine PU.1 protein (GST-PU.1) was used as anity reagent. The GST-PU.1 fusion protein was mixed with extracts prepared from either non-transfected or mouse CBP-transfected 293T cells and then precipitated to glutathione-agarose beads. Bound proteins were eluted and were then analysed by SDS ± PAGE followed by Western blot analysis. As shown in Figure 2 , CBP protein of 293T cells bound to GST-PU.1 (lane 5), but not to GST alone (lanes 3 and 4). Exogenous expression of CBP could enhance the binding (lane 6). Additionally, we wondered whether endogenous CBP interacts with PU.1 in hematopoietic cell lines. To investigate this, GST-PU.1 fusion protein was incubated with lysates prepared from MEL cells and human K562 cells. The results showed that endogenous CBP from the hematopoietic cell lines was also able to bind to PU.1 (data not shown). These results, consistent with the results obtained with yeast, indicate that PU.1 can directly bind to CBP in vitro.
Sequences required for PU.1 and CBP interaction
To delineate the regions of PU.1 required for interaction with CBP, we prepared extracts from 293T cells transfected with a mouse CBP expression vector and a number of GST-PU.1 deletion mutants ( Figure 3a ) and then tested their ability to interact with CBP. CBP protein was retained on the full length PU.1 (GST-PU.1) and on PU.1 with a deletion of the Ets domain (GST-PU.1DE). However, CBP failed to be retained on PU.1 with a deletion of the activation domain (GST-PU.1DA) nor the Ets domain alone (GST-PU.1 Ets domain) ( Figure 3b ). These results suggest that the region of PU.1 that interacts with CBP spans the transcriptional activation domain, present within residues 74 ± 122.
The regions of CBP necessary for interaction with PU.1 were also identi®ed. GST fusion proteins containing sequences 1 ± 312, 313 ± 1098 and 1283 ± 1915 of CBP were used as ligands for GST binding assay ( Figure 4a ). The fusion proteins were mixed with extracts prepared from mouse PU.1-transfected 293T cells and subjected to the assay. PU.1 interacted strongly with GST-CBP (1283 ± 1915 , which encompasses the E1A-binding domain, and weakly with GST-CBP (1 ± 312), containing the region to interact with nuclear hormone receptors, whereas it did not interact with GST-CBP (313 ± 1098) ( Figure 4b ). These results indicate that CBP directly contacts PU.1 via the region spanning amino acids 1283 ± 1915 strongly and via the residues 1 ± 312 weakly.
CBP is a coactivator for PU.1
Because PU.1 and CBP physically interact with each other, we next investigated the functional consequence of this interaction by cotransfection of HeLa cells with corresponding expression vectors and a reporter construct whose transcription is driven by trimerized In vitro association of CBP with PU.1. GST alone or GST-full length PU.1 fusion proteins was incubated with extracts prepared from either non-transfected 293T cells or mouse CBPtransfected 293T cells (*) and then precipitated with glutathioneagarose beads. Complexes were washed, bound proteins were eluted and analysed by SDS ± PAGE. Bound proteins to GST beads (lanes 1, 3 and 4), GST-PU.1 beads (lanes 2, 5 and 6) and input for CBP (lanes 7 and 8) were applied and followed by Western blotting using anti-CBP antibody PU.1 binding site. As shown in the right panel of Figure 5a , over-expression of PU.1 increased the promoter activity by 2.2-fold. CBP synergistically enhanced the activity of PU.1 by 3.8-fold, although overexpression of CBP alone had no eect on this promoter. Additionally, CBP lacking of the region required for the interaction with PU.1 did not synergistically activate the transcription by PU.1. As HeLa cells do not express PU.1 endogenously, the synergistic eect was easily detected. Control experiments with a luciferase reporter construct devoid PU.1 binding sites (Figure 5a left) demonstrate that the observed eects were binding-site speci®c. Cotransfection of the PU.1 expression vector with increasing quantities of the CBP expression vector resulted in a dose-dependent increase of luciferase activity ( Figure  5b ). These results indicate that CBP functions as a coactivator for the transcription factor PU.1.
Discussion
Transcriptional regulation requires the participation of several classes of proteins including basic and sequence-speci®c transcriptional activators and transcriptional coactivator or corepressors through proteinprotein interaction. We have tried to identify novel proteins that interact with the B cell and macrophagespeci®c transcription factor, PU.1 by yeast two-hybrid system. Sequence analyses of several b-galactosidase positive clones revealed that one of these clones encoded the transcriptional coactivator, CREB binding protein (CBP). Direct physical interactions between PU.1 and CBP was proven by GST binding assay. PU.1 has been reported to interact with retinoblastoma protein (Rb) and TFIID through the N-terminal region (1 ± 75 aa) (Hagemeier et al., 1993) , NF-EM5/Pip through the PEST domain (119 ± 160 aa) (Eisenbeis et al., 1995) and NF-IL6b through the Ets domain (245 ± 272 aa) (Nagulapalli et al., 1995) . The segment of PU.1 sucient for interaction with CBP was determined within the activation domain (74 ± 122 aa). The region of PU.1 responsible for these interactions diers upon the protein partners. It is possible that PU.1 assembles dierent combinations of cofactors depending on cell and promoter context. CBP is a large molecule that includes several sites for interaction with various sequence-speci®c transcription factors. Our in vitro binding studies mapped the region of CBP required for binding to PU.1 between residues 1283 ± 1915 containing the binding site for E1A. We also detected the sequences amino-terminal region of the CBP (1 ± 312) can provide weak interaction with PU.1 (Figure 4b) . 1DA (D74 ± 122), PU.1DE (D165 ± 256) and PU.1 Ets domain (165 ± 256) were expressed as GST fusion proteins. Coomasie brilliant blue staining of the GST fusion proteins is shown in the left panal. These fusion proteins were bound to glutathione-agarose and incubated with whole cell extracts from 293T cells expressing CBP. After washing, speci®cally associated proteins were resolved by SDS ± PAGE, transferred to PVDF membrane and then detected with anti-CBP antibody (right panel)
Interaction between PU.1 and CBP H Yamamoto et al CBP and the related p300 function by bridging between sequence-speci®c transcriptional activators and general transcription factors of the basal transcription machinery (Janknecht and Hunter, 1996) . CBP/p300 are believed to enhance transcription by targeted acetylation of speci®c chromatin domains with their intrinsic histone acetyltransferase (HAT) activities (Ogryzko et al., 1996) . Our transfection experiments showed that PU.1 and CBP synergistically cooperated to stimulate transcription in a dose dependent manner but CBP lacking of the region for the interaction with PU.1 did not augment transcription (Figure 5a and b) . Thus, our data support the model that CBP serves as a coactivator for PU.1. CBP/p300 have been shown to function as a transcriptional coactivator of several transcription factors including cyclic AMP response element-binding protein (CREB) (Chrivia et al., 1993; Kwok et al., 1994) , AP-1 (Fos/Jun) (Arias et al., 1994; Bannister and Kouzarides, 1995) , c-Myb (Dai et al., 1996; OelgeschlaÈ ger et al., 1996) , p53 , nuclear hormone receptors (NHRs) Kamei et al., 1996) , NF-kB (Gerristsen et al., 1997; Perkins et al., 1997) and STAT proteins (Bhattacharya et al., 1996; . Since CBP is a limiting cellular component (Tanaka et al., 1997) , competition or sequestration of limiting amounts of CBP by dierent transcription factors may allow negative cross talk between dierent signaling pathways. Functional interference between NHRs and AP-1 have been proposed to be a result of competition for limiting amounts of CBP/p300 in cells (Kamei et al., 1996) . A mutual antagonistic eect has also been reported between NHRs and PU.1 (Gauthier et al., 1993 ). Since we found that PU.1 weakly bind to a region of the N-terminus of CBP overlapping with the NHR binding site, it is possible that the negative cross talk between NHRs and PU.1 may be mediated by CBP. Furthermore, since it is known that several NHRs aect normal dierentiation of erythroid cells (Beug et al., 1996) and PU.1 inhibits erythroid dierentiation in MEL cells (Rao et al., 1997; Yamada et al., 1997) , transcriptional interference between NHRs and PU.1 seems to be involved in the blockage of the normal erythroid dierentiation. PU.1 may interfere with the action of NHRs by competing for limiting common cofactors (CBP/p300) and this regulatory sequestration may contribute to the control of gene activity (Janknecht and Hunter, 1996; Giles et al., 1998) . Since CBP has been recently reported to be involved in positive cross talk between NHRs and hematopoietic bZip protein p45/NF-E2 , PU.1 may interfere the ternary complex formation among NHRs, p45/NF-E2 and CBP, which appears critical for erythroid and megakaryocytic dierentiation (Shivdasani et al., 1995; Gong et al., 1996) .
During preparation of this manuscript, it has just been reported that Ets-1 and GATA-1 bind CBP/p300 (Blobel et al., 1998; Yang et al., 1998) . Ets-1 binds a second cysteine-and histidine-rich region of CBP between residues 1449 and 1892, and GATA-1 binds CBP (1283 CBP ( ± 1915 were expressed as GST fusion proteins. Coomasie brilliant blue staining of the GST fusion proteins is shown in the left panel. We used the same batch of GST as a control. The 27 kDa of GST band is not visible in this condition because of detection of high molecular weight protein. These proteins were bound to glutathion-agarose and incubated with whole cell extracts from 293T cells expressing PU.1. After washing, speci®cally associated proteins were resolved by SDS ± PAGE, transferred to PVDF membrane, and then detected with anti-PU.1 antibody (right panel) the region of CBP between residues 1626 and 2260. These sites are the E1A-binding region of CBP (Arany et al., 1995; Lundblad et al., 1995) that are located near the binding site for PU.1 (1283 ± 1915 aa) determined in the present study. Ets-1 and GATA-1 are known to promote erythroid dierentiation (Shivdasani and Orkin, 1996) , while PU.1 is downregulated during erythroid dierentiation and overexpression of PU.1 inhibits dierentiation of MEL cells (Schuetze et al., 1993; Yamada et al., 1997) . Thus, it is very tempting to speculate that PU.1 could inhibit erythroid dierentiation by transrepressing the function of Ets-1 and GATA-1 due to competition for limiting amounts of CBP.
Hematopoietic cell dierentiation involves differential expression of speci®c genes essential for the acquisition of the blood cell maturation, which are cooperatively controlled by combination of several hematopoietic transcription factors. PU.1 belongs to the ets family, many of which are expressed in a tissuerestricted fashion and therefore may control the expression of tissue-speci®c genes (Wasylyk et al., 1993; Moreau-Gachelin, 1994) . PU.1 is expressed in B-cells and macrophages and regulates cell lineagespeci®c genes in conjugation with other hematopoietic transcription factors. In fact, AML1, Myb and C/EBP share a common set of target genes with PU.1 especially in myeloid-speci®c genes. Tenen et al., 1997) . Interestingly, recent reports showed that AML1 and c-Myb also bind to CBP (Bellon et al., 1997; Kitabayashi et al., 1998) . Thus, cooperative recruitment of CBP resulting in the formation of a multimolecular complex including these transcription factors and CBP may be involved in activation of the myeloid-speci®c gene promoters and enhancers, which is critical for myeloid differentiation. Accordingly, synergistic and antagonistic interactions between PU.1 and its numerous transcription factor partners might play an important role for ®ne tuning the kinetics of hematopoietic dierentiation in erythroid and myeloid cells. An important goal for future study is to de®ne the physiological role of complex formation of PU.1 with CBP in the process of hematopoietic cell dierentiation.
Materials and methods

Plasmids and constructs
The expression vector containing the full length mouse CBP cDNA (pRc/RSV-CBP) and the plasmid of the full length mouse PU.1 cDNA were kindly provided by Drs RH Goodman and D Kabat, respectively. Fragments of CBP and PU.1 coding sequence were subcloned in frame into pGEX vectors (Pharmacia Biotech). The pGEX-PU.1, pGEX-PU.1DA, pGEX-PU.1DE and pGEX-PU.1-Ets domain plasmids encode fusion proteins between GST and PU.1-amino acids 1 ± 272, PU.1 with a deletion of 74 ± 122 or with a deletion of 165 ± 256 and PU.1-Ets domain 165 ± 265, respectively. The pGEX-CBP936, pGEX-CBP2355 and pGEX-CBP1896 plasmids encode fusion proteins between GST and CBP-amino acid 1 ± 312, 313 ± 1098 and 1283 ± 1915, respectively. Fragments of full length CBP and CBP with deletion 1283 ± 1915 were subcloned in frame into the pCDNA3.1 (Invitrogen). The reporter plasmid pGL3-PU(63)-promoter luc was constructed by inserting the double stranded trimerized 27mer oligonucleotides corresponding to the sequence in the SV40 enhancer (5'-gatcTCCTCTGAAAGAGGAACTTGGTG-3') in the BglII site of the vector pGL3-promoter-luc (Promega).
Yeast two-hybrid system
Full length mouse PU.1 cDNA was inserted into the plasmid pGBT9 containing the GAL4 DNA binding domain. The MEL cell cDNA library was constructed in the plasmid pGAD10 containing the GAL4 activation domain using Two-Hybrid cDNA Library Construction Kit (CLONTECH). Yeast two-hybrid screening was done using MATCHMAKER TM Two-Hybrid System according to the company's protocol (CLONTECH). Database searches were performed using the BLAST network service at the NCBI. The two prey vectors, pGAD424-CBP-N (313 ± 1098) and pGAD424-CBP-C (1283 ± 1915), were constructed in pGAD424 by inserting the corresponding portion of the N-and C-terminus of CBP. SFY526 yeast cells were cotransformed with the pGBT9-PU.1 bait plasmid and each pGAD424-CBP construct and then tested for expression of lacZ by the b-galactosidase ®lter assay.
Glutathione S-transferase (GST) binding assay
GST fusion proteins were expressed in Escherichia coli DH5a and puri®ed according to the manufacturer's directions (Pharmacia Biotech). CBP or PU.1 expression vector was transiently transfected into 293T cells by CaPO 4 method and then whole cell extracts were prepared in lysis buer (1% Triton X-100, 150 mM NaCl, 10 mM Tris pH 7.4, 1 mM EDTA, 1 mM EGTA, 0.2 mM sodium vanadate, 0.2 mM PMSF, 0.5% NP-40). Approximately 500 mg of fusion proteins were immobilized to glutathioneagarose, washed extensively in binding buer (same with above lysis buer) and incubated with 150 ml of 293T cell extracts at 48C for 2 h. Bound proteins were washed ®ve times with binding buer, eluted with reduced glutathione, boiled 2 min in 10 ml of 26SDS gel sample buer and subjected to SDS/PAGE. Eluted proteins were detected by Western blot analysis as detailed before (Kihara-Negishi et al., 1998) . After transfer to PVDF membrane, gels were stained by Coomasie brilliant blue to visualize GST fusion protein. Speci®c antibodies for PU.1 and CBP/p300 were purchased from Santa Cruz Biotechnology.
DNA transfection and luciferase assay
Plasmid DNA was transiently transfected into HeLa cells by Superfect (QIAGEN). For each transfection, 2610 5 cells and 1 mg of pGL3-PU(63)-luc reporter construct and 1.5 mg of expression vectors for PU.1 and/or CBP were used. All transfection experiments were done in duplicate. The cells for luciferase assay were harvested 48 h after transfection. Preparation of extracts and enzyme assay were carried out by Luciferase Assay System (Boehringer Mannheim).
